Suraksha Diagnostic Limited (NSE:SURAKSHA)

Market Cap	15.84B
Revenue (ttm)	2.64B
Net Income (ttm)	332.83M
Shares Out	52.08M
EPS (ttm)	6.28
PE Ratio	48.40
Forward PE	39.49
Dividend	n/a
Ex-Dividend Date	n/a

Volume	20,605
Average Volume	30,024
Open	300.00
Previous Close	300.80
Day's Range	300.00 - 304.80
52-Week Range	233.15 - 449.00
Beta	n/a
RSI	48.18
Earnings Date	Aug 8, 2025

About Suraksha Diagnostic

Suraksha Diagnostic Limited operates a chain of diagnostic centers in India. It offers pathology testing services, such as microbiology, serology, molecular biology, histopathology, cytopathology, clinical pathology, and haematology; genomics testing, including microarray, noninvasive prenatal, quantitative fluorescent polymerase chain reaction, fluorescence in situ hybridization, and karyotyping; and radiology testing that includes X ray, magnetic resonance imaging, computed tomography scan, USG, DEXA scan, OPG, and mammography. The company al...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1992
• Employees: 1,300
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: SURAKSHA

Financial Performance

In 2024, Suraksha Diagnostic's revenue was 2.52 billion, an increase of 15.26% compared to the previous year's 2.19 billion. Earnings were 318.24 million, an increase of 34.70%.